Abstract
In summary, we have showed that levels of COX-2 are increased in both TCC and RCC derived from urinary tract epithelium as well as gastrointestinal cancer. These results raised the possibility that selective inhibitors of COX-2 may be useful in the prevention or treatment of these diseases.
MeSH terms
-
Base Sequence
-
Carcinoma, Renal Cell / enzymology*
-
Carcinoma, Renal Cell / genetics
-
Carcinoma, Transitional Cell / enzymology
-
Carcinoma, Transitional Cell / genetics
-
Cyclooxygenase 2
-
DNA Primers
-
Gene Expression Regulation, Enzymologic
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Isoenzymes / genetics*
-
Kidney Neoplasms / enzymology*
-
Kidney Neoplasms / genetics
-
Membrane Proteins
-
Prostaglandin-Endoperoxide Synthases / genetics*
-
RNA, Messenger / genetics
-
Reverse Transcriptase Polymerase Chain Reaction
-
Urinary Bladder / enzymology*
-
Urinary Bladder Neoplasms / enzymology*
-
Urinary Bladder Neoplasms / genetics
Substances
-
DNA Primers
-
Isoenzymes
-
Membrane Proteins
-
RNA, Messenger
-
Cyclooxygenase 2
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases